Transcriptional repressor CTCF
Transcriptional repressor CTCF (102-110) is a synthetic peptide fragment derived from the CCCTC-binding factor (CTCF), a highly conserved zinc finger protein known for its pivotal role in chromatin organization and transcriptional regulation. This peptide encompasses amino acids 102 through 110 of the CTCF protein, a region that may contribute to its DNA-binding properties and regulatory functions. As an isolated sequence, it serves as a valuable tool for dissecting the structure-function relationships within CTCF, enabling researchers to investigate specific domains involved in gene expression control, chromatin insulation, and epigenetic modulation. Its defined sequence and origin from a functionally significant region make it particularly relevant for studies focused on protein-protein interactions, DNA recognition motifs, and the molecular mechanisms underpinning transcriptional repression.
Epigenetics research: The 102-110 fragment of CTCF offers a precise means to probe the role of CTCF in the establishment and maintenance of epigenetic boundaries. By using this peptide in in vitro assays, researchers can study its capacity to interfere with or mimic the native protein's interaction with chromatin and associated regulatory factors. Such studies are instrumental in elucidating how discrete regions of CTCF contribute to the formation of topologically associating domains (TADs) and the insulation of chromatin, advancing our understanding of genome architecture and its regulatory implications.
Protein interaction mapping: As a defined segment of the CTCF protein, the peptide can be employed in binding assays to identify and characterize interaction partners. Pull-down experiments, surface plasmon resonance, or co-immunoprecipitation assays utilizing this peptide enable the mapping of protein-protein interaction networks involving CTCF, particularly those that depend on its N-terminal domains. Insights gained from these studies may reveal new regulatory complexes or cofactors that modulate transcriptional repression and chromatin organization.
Antibody validation and epitope mapping: The sequence corresponding to residues 102-110 of CTCF can serve as a specific antigenic determinant for generating or validating antibodies targeting this region. Researchers can use the peptide to ascertain antibody specificity in immunoassays such as ELISA, western blotting, or immunoprecipitation. This approach is essential for ensuring the accuracy of experiments that rely on antibody-based detection of CTCF, especially when distinguishing between isoforms or post-translationally modified states.
Peptide-based inhibitor development: The synthetic fragment may be utilized as a template or reference in the development of peptide-based modulators designed to disrupt CTCF-mediated interactions. By analyzing how this segment interacts with DNA or binding partners, scientists can design competitive inhibitors or mimetics that selectively target CTCF's functional domains. Such applications are valuable in probing the biological significance of specific CTCF interactions in cell-based models and in the broader context of gene regulation studies.
Structural and biophysical characterization: The defined nature of the CTCF (102-110) peptide makes it suitable for structural and biophysical analyses aimed at elucidating the conformational properties of this protein region. Techniques such as nuclear magnetic resonance (NMR) spectroscopy, circular dichroism, or crystallography can be applied to the peptide to determine its secondary structure tendencies and its potential to adopt specific conformations when interacting with nucleic acids or proteins. These insights contribute to a more detailed understanding of how CTCF domains mediate their diverse regulatory functions at the molecular level.
2. Myotropic activity of allatostatins in tenebrionid beetles
3. Store-operated Ca2+ entry sustains the fertilization Ca2+ signal in pig eggs
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More